Strategy

Gimv Life Sciences focuses on investments in a wide variety of biotech companies in different geographical markets, but with a primary European focus.

Target investees specialise in

• drug discovery and development
• diagnostics
• medical devices
• technologies to be applied in agriculture or in white biotech

Gimv can support companies in every development phase, from early stage to listed.

The Life Sciences team consists of three experienced investment professionals. Thanks to their industry knowledge, track record and extensive network, they can thoroughly assess new investment opportunities and create added value. Through a proactive hands-on approach, the team contributes to the permanent growth and success of its portfolio companies.